IMR Press / EJGO / Volume 25 / Issue 5 / pii/2004230

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Open Access Distinguished Expert Series

Role of lymphadenectomy in management of adenocarcinoma of the endometrium

Show Less
1 Professor, Obstetrics-Gynecology, Indiana University School of Medicine, Indianapolis, IN (USA)
Eur. J. Gynaecol. Oncol. 2004, 25(5), 545–551;
Published: 10 October 2004
Abstract

Purpose: To review the role of lymphadenectomy (LND) for patients with endometrial adenocarcinoma. Methods: A review was undertaken of the English Language literature dealing with the role of LND for patients with endo­metrial adenocarcinoma (EC). Results: The prognostic value of node status for EC patients has been recognized. LND performed by experienced surgeons has acceptable morbidity. Multiple series have suggested that significantly less external beam radiation is given to patients with known negative nodes. The decreased use of postop whole pelvic radiation has potential cost savings. However a sur­vival advantage for LND has not yet been proven in a randomized clinical trials. United Kingdom investigators have begun a trial to determine if there is a demonstrable survival advantage for EC patients who undergo LND. Conclusion: Although the morbidity, potential cost savings, and prognostic impact of node status are well accepted, it remains controversial as to whether LND provides a survival advantage. Trials are underway.

Keywords
Surgical staging
Endometrial adenocarcinoma
Share
Back to top